Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Coronavirus disease	8/232	1.7599698728274597e-11	1.5487734880881646e-09	140.07142857142858	-334.06967394373197	C3;DDX58;IFIH1;IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Influenza A	7/172	1.9983189397745542e-10	8.792603335008038e-09	111.75959595959596	-326.1978352313282	DDX58;IFIH1;IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Legionellosis	5/57	3.5877996201909306e-09	1.017456116327496e-07	154.15384615384616	-361.8273890688762	C3;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Measles	6/139	4.6248005287613455e-09	1.017456116327496e-07	89.49248120300751	-271.8328210630055	DDX58;IFIH1;IFNA1;IL1B;IL6;TLR4
KEGG_2021_Human	Hepatitis B	6/162	1.1657637504621833e-08	2.0517442008134428e-07	76.07692307692308	-238.99790749378803	DDX58;IFIH1;IFNA1;IL6;TLR4;TNF
KEGG_2021_Human	Pertussis	5/76	1.5675128124076017e-08	2.2990187915311494e-07	112.63380281690141	-288.85723035226965	C3;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Tuberculosis	6/180	2.1972983034080995e-08	2.7623178671416106e-07	68.05172413793103	-218.31921709295966	C3;IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	5/104	7.689793164389816e-08	7.51890887184782e-07	80.4949494949495	-223.94034919826578	IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Chagas disease	5/102	6.972006864965533e-08	7.51890887184782e-07	82.17525773195877	-227.56322024445333	C3;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	2.335679140930417e-06	116.26086956521739	-240.55570695978312	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	7/498	3.3127242426844717e-07	2.6501793941475773e-06	36.00746775288527	-125.29269699884674	C3;DDX58;IFIH1;IFNA1;IL1B;IL6;TNF
KEGG_2021_Human	Necroptosis	5/159	6.457403055921121e-07	4.611124051206705e-06	51.38961038961039	-155.93286055355003	HMGB1;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	4/63	6.811887802918996e-07	4.611124051206705e-06	90.49717514124293	-200.30830604753126	DDX58;IFNA1;IL1B;IL6
KEGG_2021_Human	Inflammatory bowel disease	4/65	7.733227471018954e-07	4.8608858389262e-06	87.50819672131148	-195.3419859289311	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	4/70	1.044163095458912e-06	6.125756826692284e-06	80.82828282828282	-183.98664919066243	DDX58;IFIH1;IFNA1;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	5/181	1.2298084205616124e-06	6.763946313088868e-06	44.84090909090909	-138.94613864677578	IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	7.944212984953218e-06	73.01369863013699	-170.21630123625883	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Lipid and atherosclerosis	5/215	2.882246411730869e-06	1.4090982457350915e-05	37.41904761904762	-118.71127334987257	IFNA1;IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Rheumatoid arthritis	4/93	3.2795638728842682e-06	1.518955899020082e-05	59.767790262172284	-145.5024915816698	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Amoebiasis	4/102	4.7476288106462685e-06	2.0889566766843584e-05	54.21768707482993	-134.5540755438832	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	5.130876847568527e-06	2.1500817266001443e-05	53.12	-132.3420645012429	DDX58;IL1B;TLR4;TNF
KEGG_2021_Human	African trypanosomiasis	3/37	1.0384632752750053e-05	4.1538531011000214e-05	101.26890756302521	-158.85054794063166	IL1B;IL6;TNF
KEGG_2021_Human	Graft-versus-host disease	3/42	1.5293149491516165e-05	5.633370726802613e-05	88.23076923076923	-143.80928698800247	IL1B;IL6;TNF
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	5.633370726802613e-05	39.774436090225564	-104.03256013781805	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00022605056592292776	27.202072538860104	-74.37625984844887	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	Epstein-Barr virus infection	4/202	7.083103438365334e-05	0.00023973580868313438	26.4983164983165	-72.60755777125968	DDX58;IFNA1;IL6;TNF
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.0003515298291687853	23.671191553544496	-65.36509727839072	IFNA1;IL1B;IL6;TNF
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0004793516339823928	21.55922865013774	-59.801482853342776	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.000485076634594841	21.287074829931974	-59.07439560833883	IL1B;IL6;TLR4;TNF
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0005063186010302107	37.56828885400314	-73.71479219141467	IL1B;IL6;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.000570366915044004	35.2179675994109	-69.8003308229761	IL1B;IL6;TNF
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.000570366915044004	35.589285714285715	-70.42440314178907	IL1B;IL6;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0006212463778956368	33.806223479490804	-67.40758155759835	IL1B;IL6;TNF
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.0007507393480160471	31.293577981651374	-63.06696788213405	IL1B;IL6;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	4/295	0.0003074189702429336	0.000772939125182233	17.81672394043528	-49.58458596249444	IFNA1;IL1B;IL6;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.001840955229060077	22.31954887218045	-46.57552582678881	IL1B;IL6;TNF
KEGG_2021_Human	Hepatitis C	3/157	0.0007818177127513567	0.0018594583438410646	22.024118738404454	-46.00245527612638	DDX58;IFNA1;TNF
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.002807438123261613	48.94512195121951	-56.84526782917664	IL1B;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.003023473320927053	18.161290322580644	-38.30003183551744	C3;HMGB1;TLR4
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.003131842802016461	17.769924812030077	-37.496518500419114	C3;IFNA1;IL6
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.0040049452867091245	16.115516062884485	-34.04865723073064	IFNA1;TLR4;TNF
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.008045249358410469	12.377777777777778	-25.926933584065353	IL1B;IL6;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.01066713561352879	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.012799556430416945	20.331632653061224	-27.120602948412195	IL6;TNF
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.01416381995867253	18.778301886792452	-25.204052222837845	IL6;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.01416381995867253	18.95952380952381	-25.42995427691617	IL1B;IL6
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.01416381995867253	18.600467289719628	-24.98176436194636	IL6;TLR4
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.0143189581735229	9.422466422466423	-19.140881053489387	IFNA1;IL6;TLR4
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.0143189581735229	18.086363636363636	-24.33571316400054	TLR4;TNF
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.015706336528426967	9.018735362997658	-18.187178129854335	IL1B;IL6;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.017533265489938544	15.886	-21.510038502238015	IL1B;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.018252451789121365	15.385658914728682	-20.853034219946885	IFNA1;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.018972465003029064	14.915413533834586	-20.230385574789178	C3;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.019693019856354844	14.472627737226277	-19.639406588988233	IL1B;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.022936968369576035	13.196666666666667	-17.909946150058477	C3;TLR4
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.025430712011195754	12.35625	-16.748364182562245	IFNA1;IL6
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.027437730469084758	6.897094430992736	-13.07371705691191	IL1B;IL6;TNF
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.038265574452137886	9.685960591133005	-12.928804077098514	TLR4;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.0425479118835177	9.044930875576037	-11.980722307867735	IL6;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.055352765511573594	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Base excision repair	1/33	0.040130782413471976	0.05789358774402514	27.90277777777778	-15.299431750604054	HMGB1
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.0654082318103257	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.06841509634101978	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.07636428908345196	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.07837157595816653	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.08080575511672394	5.880699088145897	-7.115618067766183	IFNA1;TNF
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.08371973102050545	17.128205128205128	-10.081098986019231	IFNA1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.10490071887521428	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.10490071887521428	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.1163089861495186	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Complement and coagulation cascades	1/85	0.10043221696214563	0.12447936750237769	10.56084656084656	-6.37671991533167	C3
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.1282433724642237	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.13228466097606623	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.13228466097606623	9.425531914893616	-5.678293992521663	C3
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.13228466097606623	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.13311679045271307	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.138971615317883	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.15371468378238334	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.15371468378238334	3.5628544423440456	-3.410136075895621	IFNA1;IL6
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.16600099216007022	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.17089655444138213	6.480392156862745	-3.763669230249352	HMGB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.17449378851529032	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.18570174420738644	5.672401433691756	-3.209640069203435	IL6
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.18570174420738644	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.22146347941879002	4.5823152995927865	-2.441961042053517	IL6
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.23004442175351072	4.326732673267327	-2.2588473265567357	C3
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.3545262994685031	2.5254901960784313	-0.9533164047874388	C3
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
